Drug Type mRNA |
Synonyms |
Target |
Action modulators |
Mechanism USP6 modulators(ubiquitin specific peptidase 6 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
RegulationOrphan Drug (United States) |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Sarcoma | Preclinical | United States | 30 Sep 2024 | |
| Solid tumor | Preclinical | United States | 30 Sep 2024 |





